Patents by Inventor Ricardo J. Parker

Ricardo J. Parker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treating ovarian cancers with cadmium
    Patent number: 6676973
    Abstract: A method is provided for treating an ovarian cancer in a human or other mammalian patient suffering from the ovarian cancer, the method comprises administering to the human or the other mammalian patient an effective ovarian cancer treating amount of cadmium, preferably in the form of cadmium chloride. Pharmaceutical compositions and pharmaceutical kits which are useful in practicing the described method of treating ovarian cancer in the human or other mammalian patient suffering from the ovarian cancer are also provided for in the disclosure.
    Type: Grant
    Filed: March 3, 1995
    Date of Patent: January 13, 2004
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Kang Bo Lee, Ricardo J. Parker, Eddie Reed
  • Radiation resistance assay for predicting treatment response and clinical outcome
    Patent number: 6261795
    Abstract: The present invention provides a novel method for assaying radiation resistance of cancer cells by isolating cancer cells, irradiating the cells, incubating the cells with a labeled marker indicative of cell proliferation, measuring the amount of labeled marker incorporated into the cells in order to determine the effect of radiation on the proliferation of cells, and then determining the relative resistance of the cells to radiation. Also provided are methods of assaying radiation resistance of cancer cells which are exposed to radiation and radio-sensitizing or chemotherapeutic agents.
    Type: Grant
    Filed: May 17, 1999
    Date of Patent: July 17, 2001
    Assignee: Oncotech, Inc.
    Inventors: John P. Fruehauf, Ricardo J. Parker
  • Radiation resistance assay for predicting treatment response and clinical outcome
    Patent number: 6008007
    Abstract: The present invention provides a novel method for assaying radiation resistance of cancer cells by isolating cancer cells, irradiating the cells, incubating the cells with a labeled marker indicative of cell proliferation, measuring the amount of labeled marker incorporated into the cells in order to determine the effect of radiation on the proliferation of cells, and then determining the relative resistance of the cells to radiation. Also provided are methods of assaying radiation resistance of cancer cells which are exposed to radiation and radio-sensitzing or chemotherapeutic agents.
    Type: Grant
    Filed: January 31, 1997
    Date of Patent: December 28, 1999
    Assignee: Oncotech, Inc.
    Inventors: John P. Fruehauf, Ricardo J. Parker